Cannabis Oil Use by Adolescents and Young Adults With Inflammatory Bowel Disease

538

Objectives:  The aim of the study was to describe use of oral or sublingual cannabis oil (CO) by adolescent and young adult patients with inflammatory bowel disease (IBD). Methods:  A descriptive study of IBD patients 13 to 23 years of age seen between January 2015 through December 2017 at Children’s Hospital Colorado. Information obtained included chart abstraction, electronic and interview self-report, and serum cannabinoid levels.

Ga naar Bron